Sriram Ryali holds the position of Chief Financial Officer of Eiger BioPharmaceuticals, Inc.

Mr. Ryali previously occupied the position of Senior Director-Financial Planning & Analysis at Jazz Pharmaceuticals Plc, Head-Corporate Finance at Onyx Pharmaceuticals, Inc. and Vice President-Finance at Aimmune Therapeutics, Inc.

He received an undergraduate degree from the University of California, Los Angeles and an MBA from UCLA Anderson School of Management.